Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680653 · ClinicalTrials.gov registry record · NA
Testing State of the Art Remote Glucose Monitoring at Diabetes Camp
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT01680653: Completed NA study, sponsored by Stanford University.
NCT01680653 is a NA study that has completed, run by Stanford University. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01680653, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The incidence of low blood sugar and hypoglycemic seizures at diabetes camp has been reduced thanks to overnight blood glucose level testing. The timing of the overnight blood test is often arbitrary and it is unclear when the highest frequency of nocturnal hypoglycemic events at camp are occurring. It is also unclear what the most appropriate treatment for nocturnal hypoglycemia is: simple carbohydrates, or mini-glucagon. In this study, we will use Continuous Glucose Monitors (CGMs) that will send subject data securely to a remote computer located in the medical cottage at camp throughout the night. Study staff will monitor the computer and will intervene on low blood sugar as it occurs in real time. On half of the nights, campers will receive mini-glucagon for low blood sugar, and on the rest, they will receive standard carbohydrate treatment.
Interventions
- DRUG Mini-glucagon
- DEVICE Remote monitoring
- DIETARY_SUPPLEMENT Carbohydrates
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680653
The ClinicalTrials.gov registry entry for NCT01680653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mini-glucagon is the first listed.
NCT01680653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01680653 about?
NCT01680653 is a clinical study titled "Testing State of the Art Remote Glucose Monitoring at Diabetes Camp". The incidence of low blood sugar and hypoglycemic seizures at diabetes camp has been reduced thanks to overnight blood glucose level testing. The timing of the overnight blood test is often arbitrary and it is unclear when the highest frequency of nocturnal hypoglycemic events at camp are occurring....
What is the current status of trial NCT01680653?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2012-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01680653?
The interventions under investigation include: Mini-glucagon (DRUG), Remote monitoring (DEVICE), Carbohydrates (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01680653?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.